Neogen targets adjusted gross margin in high-50% range by FY2031
NEOG•Neogen targets an adjusted gross margin in the high-50% range and a 30% adjusted EBITDA margin by FY2031. It plans to increase R&D investment by 50% in FY2027, reach 5% of revenue by FY2031, and keep net leverage below 2.5x.
1. FY2031 targets
Neogen said it targets an adjusted gross margin in the high-50% range, a 30% adjusted EBITDA margin and net leverage below 2.5x by FY2031. The company plans to increase research and development investment by 50% in FY2027 and target R&D investment equal to 5% of revenue by FY2031.
